SEVİNDİK, Ö. G. Et Al. 2017. Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience. AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ , (United States Of America), 5405.

SEVİNDİK, Ö. G., PEHLİVAN, M., TUĞLULAR, A. T., solmaz, ş. m., DOĞU, M. H., YALNIZ, F. F., ... URAL, A. U.(2017). Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience . AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ (pp.5405). , United States Of America

SEVİNDİK, ÖMÜR Et Al. "Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience," AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ, United States Of America, 2017

SEVİNDİK, ÖMÜR G. Et Al. "Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience." AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ , United States Of America, pp.5405, 2017

SEVİNDİK, Ö. G. Et Al. (2017) . "Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience." AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ , United States Of America, p.5405.

@conferencepaper{conferencepaper, author={ÖMÜR GÖKMEN SEVİNDİK Et Al. }, title={Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience}, congress name={AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ}, city={}, country={United States Of America}, year={2017}, pages={5405} }